NASDAQ:BMRA - Biomerica Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.40 -0.05 (-2.04 %)
(As of 01/21/2019 04:26 AM ET)
Previous Close$2.40
Today's Range$2.3282 - $2.50
52-Week Range$1.60 - $4.74
Volume13,431 shs
Average Volume16,864 shs
Market Capitalization$22.38 million
P/E Ratio-14.12
Dividend YieldN/A
Beta0.63
Biomerica, Inc., together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The company's diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific hormones, antibodies, antigens, or other substances, which exist in the human body in extremely small concentrations. It primarily offers its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the point-of-care and in-hospital/clinical laboratories worldwide. The company is also developing InFoods, an irritable bowel syndrome (IBS) therapy technology and diagnostic-guided therapy, which is in clinical studies to identify specific foods that when removed from the patient's diet can alleviate the patient's IBS symptoms. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.

Receive BMRA News and Ratings via Email

Sign-up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Dental equipment & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BMRA
CUSIPN/A
Phone949-645-2111

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.56 million
Book Value$0.47 per share

Profitability

Net Income$-1,460,000.00

Miscellaneous

Employees39
Market Cap$22.38 million
OptionableNot Optionable

Biomerica (NASDAQ:BMRA) Frequently Asked Questions

What is Biomerica's stock symbol?

Biomerica trades on the NASDAQ under the ticker symbol "BMRA."

How were Biomerica's earnings last quarter?

Biomerica, Inc. (NASDAQ:BMRA) issued its quarterly earnings results on Tuesday, January, 15th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.06) by $0.01. The firm earned $1.50 million during the quarter, compared to the consensus estimate of $1.51 million. Biomerica had a negative return on equity of 45.72% and a negative net margin of 36.36%. View Biomerica's Earnings History.

When is Biomerica's next earnings date?

Biomerica is scheduled to release their next quarterly earnings announcement on Monday, April 15th 2019. View Earnings Estimates for Biomerica.

What price target have analysts set for BMRA?

1 equities research analysts have issued 12-month price objectives for Biomerica's stock. Their forecasts range from $6.25 to $6.25. On average, they anticipate Biomerica's stock price to reach $6.25 in the next year. This suggests a possible upside of 160.4% from the stock's current price. View Analyst Price Targets for Biomerica.

What is the consensus analysts' recommendation for Biomerica?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biomerica in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Biomerica.

Has Biomerica been receiving favorable news coverage?

News articles about BMRA stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Biomerica earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future.

Who are some of Biomerica's key competitors?

Who are Biomerica's key executives?

Biomerica's management team includes the folowing people:
  • Mr. Zackary S. Irani, Chairman & CEO (Age 53)
  • Mr. Francis E. Capitanio, Pres (Age 75)
  • Ms. Janet Moore, CFO, Treasurer, Sec. & Director (Age 68)

How do I buy shares of Biomerica?

Shares of BMRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biomerica's stock price today?

One share of BMRA stock can currently be purchased for approximately $2.40.

How big of a company is Biomerica?

Biomerica has a market capitalization of $22.38 million and generates $5.56 million in revenue each year. The company earns $-1,460,000.00 in net income (profit) each year or ($0.17) on an earnings per share basis. Biomerica employs 39 workers across the globe.

What is Biomerica's official website?

The official website for Biomerica is http://www.biomerica.com.

How can I contact Biomerica?

Biomerica's mailing address is 17571 Von Karman Avenue, Irvine CA, 92614. The company can be reached via phone at 949-645-2111.


MarketBeat Community Rating for Biomerica (NASDAQ BMRA)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  83 (Vote Outperform)
Underperform Votes:  73 (Vote Underperform)
Total Votes:  156
MarketBeat's community ratings are surveys of what our community members think about Biomerica and other stocks. Vote "Outperform" if you believe BMRA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BMRA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2019 by MarketBeat.com Staff

Featured Article: Stop Order

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel